Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-12 · accession 0001104659-24-128431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-13 | 2024-12-12 | OBIO | Taylor Andrew Lawrence | CFO | F - Tax | $5.03 | -34.4K | 344.0K | -9% | -$173.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-12-12 | F | D | 34,403 | $5.03 | 343,960 | D | — | — | (F1) Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. |